Gynecological Cancer Research - Penn State Cancer Institute
Gynecological Cancer Research
Research into gynecological cancer at Penn State Cancer Institute is conducted by the dedicated gynecological cancer team. See current clinical trials and members of that team here.
Clinical Trials
The COVID-19 and Cancer Consortium (CCC19) Registry
Psychosocial Challenges and Educational/Occupational Aspirations of Adolescent/Young Adult Cancer Survivors
Increasing cancer screening among female patients at PSH St. Joseph s residency clinic: Offering a self-sampling option in clinic
NRG-CC008 A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
A Phase II Study Of Tailored Adjuvant Therapy In Pole-Mutated And P53- Wildtype/NSMP Early-Stage Endometrial Cancer (Rainbow Blue & Taper)
Body Image and Sexual Functioning in Patients Undergoing Treatment for Cancer/Pre-cancer of the Vulva
A Phase III Trial of One vs. Two Years of Maintenance Olaparib, with or without Bevacizumab, in Patients with BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy (NRG-GY036)
Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
Disease Team Members
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
 |
Leonard | Tuanquin | MD |
Research into gynecological cancer at Penn State Cancer Institute is conducted by the dedicated gynecological cancer team. See current clinical trials and members of that team here.
The COVID-19 and Cancer Consortium (CCC19) Registry
Psychosocial Challenges and Educational/Occupational Aspirations of Adolescent/Young Adult Cancer Survivors
Increasing cancer screening among female patients at PSH St. Joseph s residency clinic: Offering a self-sampling option in clinic
NRG-CC008 A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
A Phase II Study Of Tailored Adjuvant Therapy In Pole-Mutated And P53- Wildtype/NSMP Early-Stage Endometrial Cancer (Rainbow Blue & Taper)
Body Image and Sexual Functioning in Patients Undergoing Treatment for Cancer/Pre-cancer of the Vulva
A Phase III Trial of One vs. Two Years of Maintenance Olaparib, with or without Bevacizumab, in Patients with BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy (NRG-GY036)
Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
|
Leonard | Tuanquin | MD |